The mRNA expression of C3 and its receptor C3aR are upregulated in AD patients with tauopathy, and C3aR ablation attenuates tau pathology and reverses neuroinflammation in a tau-transgenic mouse AD model [25]. This evidence concerns the gene C3 and tauopathy.